Skip to content

Clinical trials

Phase 1/2 Bronchiolitis Obliterans Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 1/2 Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20041
20051
20062
20071
20091
20104
20113
20123
20132
20143
20151
20165
20171
20182
20194
20202
20212
20221
20231
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Active, not recruiting6
Terminated6
Recruiting4
Withdrawn2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Genta Incorporated2
H. Lee Moffitt Cancer Center and Research Institute2
Incyte Corporation2
M.D. Anderson Cancer Center2
Pharmacyclics LLC.2
Alexion Pharmaceuticals, Inc.1
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud1
Banc de Sang i Teixits1
Beijing Tide Pharmaceutical Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome50
Graft vs Host Disease9
Hematologic Neoplasms4
Leukemia4
Leukemia, Lymphocytic, Chronic, B-Cell3
Stroke3
Brain Injuries, Traumatic2
Diabetic Foot2
Hepatitis B2
Hepatitis B, Chronic2

Trials

Showing 76 to 50 of 50. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.